Trending Now
News Headlines
Global News
World
Russia, adapting tactics, advances in Donetsk and takes more Ukrainian land
POKROVSK, Ukraine — Russian forces have mounted an arc of attack in Ukraine’s eastern Donbas region, pushing through intense summer heat in a...
Business
Science
Science
‘A Roller Coaster in a Carwash’: Why Scientists Are Flying Into Hurricane Beryl
Hurricane Beryl, which devastated islands in Grenada on Tuesday and is now heading toward Jamaica and the Cayman Islands, has broken records as...
Technology
Technology
TikTok’s Survival Is at Stake in All-Out Fight Against US Ban
(Bloomberg) -- The Chinese-owned social media platform TikTok is battling a potential US ban with the signature tools of American democracy — lawyers,...
Weather
Mountain House
clear sky
59.9
°
F
64.4
°
55.3
°
78 %
7.7mph
0 %
Sat
83
°
Sun
89
°
Mon
86
°
Tue
90
°
Wed
84
°
Most Popular
Health
Woman’s hands can triple in size amid rare swelling attacks
Chloe DaviesMs Davies' HAE symptoms became "much worse" after having her daughter nine years ago. Her monthly flare-ups began occurring every four days,...
Are you feeling grotty all the time?
Getty ImagesHow are you feeling?There has been a vibe in BBC HQ that friends, colleagues and family have been having a grottier year...
EU regulator rejects Alzheimer’s drug lecanemab
Getty ImagesThe European Medicines Agency (EMA) has rejected a licence for an Alzheimer’s treatment which slows cognitive decline. The EMA said the...
An ugly earnings report from a competitor is good news for Abbott Labs
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's...
European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
European drug regulators on Friday rejected the Alzheimer's treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as they scramble...
